Parvalbumin interneuron-derived tissue-type plasminogen activator shapes perineuronal net structure

Archive ouverte

Lépine, Matthieu | Douceau, Sara | Devienne, Gabrielle | Prunotto, Paul | Lenoir, Sophie | Regnauld, Caroline | Pouettre, Elsa | Piquet, Juliette | Lebouvier, Laurent | Hommet, Yannick | Maubert, Eric | Agin, Véronique | Lambolez, Bertrand | Cauli, Bruno | Ali, Carine | Vivien, Denis

Edité par CCSD ; BioMed Central -

International audience. Background: Perineuronal nets (PNNs) are specialized extracellular matrix structures mainly found around fastspiking parvalbumin (FS-PV) interneurons. In the adult, their degradation alters FS-PV-driven functions, such as brain plasticity and memory, and altered PNN structures have been found in neurodevelopmental and central nervous system disorders such as Alzheimer's disease, leading to interest in identifying targets able to modify or participate in PNN metabolism. The serine protease tissue-type plasminogen activator (tPA) plays multifaceted roles in brain pathophysiology. However, its cellular expression profile in the brain remains unclear and a possible role in matrix plasticity through PNN remodeling has never been investigated. Result: By combining a GFP reporter approach, immunohistology, electrophysiology, and single-cell RT-PCR, we discovered that cortical FS-PV interneurons are a source of tPA in vivo. We found that mice specifically lacking tPA in FS-PV interneurons display denser PNNs in the somatosensory cortex, suggesting a role for tPA from FS-PV interneurons in PNN remodeling. In vitro analyses in primary cultures of mouse interneurons also showed that tPA converts plasminogen into active plasmin, which in turn, directly degrades aggrecan, a major structural chondroitin sulfate proteoglycan (CSPG) in PNNs. Conclusions: We demonstrate that tPA released from FS-PV interneurons in the central nervous system reduces PNN density through CSPG degradation. The discovery of this tPA-dependent PNN remodeling opens interesting insights into the control of brain plasticity.

Suggestions

Du même auteur

PKCδ-positive GABAergic neurons in the central amygdala exhibit tissue-type plasminogen activator: role in the control of anxiety

Archive ouverte | Douceau, Sara | CCSD

International audience

tPA promotes ADAMTS-4-induced CSPG degradation, thereby enhancing neuroplasticity following spinal cord injury

Archive ouverte | Lemarchant, Sighild | CCSD

International audience

Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact.

Archive ouverte | Roussel, Benoit, D | CCSD

International audience. Recombinant tissue-type plasminogen activator (tPA) is the fibrinolytic drug of choice to treat stroke patients. However, a growing body of evidence indicates that besides its beneficial thro...

Chargement des enrichissements...